Latest Nzx News

Fletcher Building has confirmed the release of government grant funds to Golden Bay Cement, enabling the purchase of New Zealand Units that underpin the plant's operation through 2040 and safeguard over 600 jobs in Whangarei.

MOVE Logistics has returned to profitability in FY26, delivering positive normalised earnings before tax alongside revenue growth and reduced net debt, despite ongoing challenges in its warehousing division.

Locate Technologies’ Q4 FY26 update highlights a 54% surge in Locate2u revenue to NZ$1.20 million, driving normalised EBITDA into positive territory. AI integration accelerated product development and customer onboarding, while capital moves included a share buyback and royalty conversion.

Tourism Holdings Limited has upgraded its FY26 underlying net profit after tax to around $46 million, beating earlier guidance. The company reports strong vehicle sales in New Zealand and robust late bookings, particularly in North America, while net debt ended lower than expected.

Genesis Energy reported an 11.6% increase in electricity netback to $189/MWh in Q4 FY26, driven by a strategic shift to a single brand and simplified product offering. Despite a 5.8% decline in total customers and lower electricity sales, the company advanced its renewables pipeline and battery storage projects while thermal generation dropped sharply due to warmer conditions.

Mercury NZ invests US$30 million for a minority stake in Datagrid NZ, aligning with its strategy to power long-term renewable demand from large-scale digital infrastructure projects.

SkyCity Entertainment Group has signed a non-binding heads of agreement to sell The Grand Hotel, aiming to boost financial flexibility through asset monetisation and debt repayment.

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

AFT Pharmaceuticals secures tentative FDA approval for Scomara cream to treat rare facial tumours but faces a US launch delay due to orphan drug exclusivity. The approval bolsters prospects in other markets where AFT expects competitive advantages.

Contact Energy's June 2026 operating report reveals rising electricity and gas sales alongside a sharp decline in generation costs and robust hydro storage. Renewable projects continue to advance, supporting the company’s clean energy ambitions.

Kingfish Limited outperformed the S&P/NZX50G with an 8.7% gross portfolio return in Q2 2026, driven by strong results from Fisher & Paykel Healthcare, Vista Group, and Infratil, while a2 Milk faced supply chain and regulatory challenges.

TradeWindow Holdings reported a 20% increase in trading revenue to $9.6 million and improved its EBITDA loss to $1.2 million, while advancing its AI-driven FreightAI platform on track for a 2027 commercial release.